Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.260
+0.040 (3.28%)
Jun 24, 2026, 4:00 PM EDT - Market closed

Neuronetics Revenue

Neuronetics had revenue of $34.45M in the quarter ending March 31, 2026, with 7.75% growth. This brings the company's revenue in the last twelve months to $151.64M, up 69.52% year-over-year. In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth.

Revenue (ttm)
$151.64M
Revenue Growth
+69.52%
P/S Ratio
0.62
Revenue / Employee
$230,450
Employees
658
Market Cap
87.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025149.16M74.27M99.17%
Dec 31, 202474.89M3.54M4.96%
Dec 31, 202371.35M6.14M9.42%
Dec 31, 202265.21M9.89M17.89%
Dec 31, 202155.31M6.07M12.32%
Dec 31, 202049.24M-13.41M-21.41%
Dec 31, 201962.66M9.88M18.72%
Dec 31, 201852.78M12.34M30.53%
Dec 31, 201740.43M6.21M18.13%
Dec 31, 201634.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xtant Medical Holdings121.91M
Outset Medical117.59M
Pulmonx88.55M
AVITA Medical72.35M
LENSAR57.70M
SANUWAVE Health44.34M
electroCore34.90M
Rapid Micro Biosystems34.38M
Revenue Rankings